Interrupting HIV treatments in hope of finding a cure
By healthline.com It might seem counterintuitive for a person living with HIV to stop their treatments. However, a new study...
Category: Spot – Anglophone Newswire
The FDA Just Approved Two HIV Drugs: Will This Change Treatment?
By healthline.com Late last month, the U.S. Food and Drug Administration approved two new medications to help treat HIV-1, the...
Global Burden of HIV-Related CVD Has Tripled Over Two Decades
By tctmd.com People with HIV are more than twice as likely to develop cardiovascular disease than those without the virus,...
Ageing with HIV: ‘Stigma will kill you before the disease’
By abc.net.au Peter (not his real name) has been keeping his HIV diagnosis a secret for more than three decades....
Eplerenone May Improve Cardiovascular Disease Risk in HIV
By infectiousdiseaseadvisor.com A treatment approach targeting mineralocorticoid receptor (MR) blockade may improve select parameters related to inflammation, lipids, and ectopic...
Carotid Artery Atherosclerosis Is Associated With Mortality in Adults With HIV
By infectiousdiseaseadvisor.com Carotid artery plaque was predictive of mortality, with differences observed by sex and HIV serostatus, according to a...
Abacavir Linked to Increased Risk for Cardiovascular Disease in PLWHIV
By infectiousdiseaseadvisor.com Exposure to abacavir is associated with an increased risk for cardiovascular disease (CVD) in individuals infected with HIV,...
Patients with HIV, CMV Face Higher Rates of Subclinical Cardiovascular Disease
By mdmag.com Patients with HIV who had high levels of cytomegalovirus (CMV) immunoglobulin G (IgG) faced an increased risk of...
Individuals with HIV at higher risk for heart disease
By medicalxpress.com Combination antiretroviral therapy (cART) consists of a « cocktail » of several drugs that work together to reduce the amount...
HIV and Aging: A Growing Population Faces Unique Challenges
By The Foundation for AIDS Research Jeff Taylor, incoming Co-chair of the Community Advisory Board of the amfAR Institute...